直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

District Court Collateral Estoppel: Materially Altering the Question of Invalidity

March 10, 2023

Authored and Edited by Milan Feliciello; Shannon M. Patrick; Amanda K. Murphy, Ph.D.

In Kroy IP Holdings, LLC v. Groupon, Inc., No. 17-cv-01405, 2022 WL 17403538 (D. Del. Dec. 2, 2022), the Court granted Groupon’s motion to dismiss Kroy IP’s amended complaint based on collateral estoppel.

On October 16, 2017, Kroy IP filed suit against Groupon in the District of Delaware, alleging that Groupon infringed U.S. Patent No. 6,061,660 (“the ’660 patent”), which claims a method and system for providing incentive programs over a computer network.  Id. at *2. In its original complaint, Kroy IP asserted 13 “exemplary” claims of the ’660 patent.  Id.

In October 2018, Groupon timely filed two inter partes reviews (“IPRs”) challenging 21 total claims of the ’660 patent, the 13 “exemplary” claims and eight additional claims.  Id. at *2–*3. A few months after Groupon filed its IPR petitions, Kroy IP filed an amended complaint.  Id. at *3. The amended complaint added 22 newly-asserted claims.  d. at *3–*4. Few of these 22 newly-asserted claims were included in Groupon’s IPR petitions because the claims were first raised after the IPR filing deadline. Id. at *4. The PTAB invalidated all asserted claims, and the Federal Circuit affirmed the PTAB’s decision on appeal.  Id.

Groupon moved to dismiss Kroy IP’s amended complaint primarily on the grounds that Kroy IP was collaterally estopped from alleging infringement of the 22 newly-asserted claims. Id. at *5, *7.

The Court explained that collateral estoppel resulting from a PTAB Final Written Decision is a form of issue preclusion, which requires that the same issue was previously adjudicated. Id. at *8. However, the claims need not be identical, in fact, “precedent does not limit collateral estoppel to patent claims that are identical.” Id. at *9 (quoting Ohio Willow Wood Co. v. Alps South, LLC, 735 F.3d 1333, 1342 (Fed. Cir. 2013)). Rather, if the “differences between the unadjudicated patent claims and adjudicated patent claims do not materially alter the question of invalidity,” then collateral estoppel applies. Id.

The Court found that the newly asserted claims contained “superficial differences” from the claims invalidated by the PTAB, and in some instances, were broader than those before the PTAB. Id. at *15–*16. For some claims, Plaintiff’s newly asserted claim was directed to a method, whereas the invalidated claim was directed to a system. Id. at *16.  The Court reasoned that the newly asserted method claim was “(1) worded nearly identically to [the invalidated system claim] and (2) makes use of all material elements of [the invalidated claim’s] system in the claimed method.” Id. at *17.  The fact that the system claim required a server did not convince the Court that the claim was valid.  Id. at *16. Ultimately, in light of the PTAB’s decision invalidating “other (slightly-differently-worded) claims of the same patent,” which did not materially alter the question of invalidity, the Court concluded that the Groupon had demonstrated that Kroy IP was collaterally estopped from asserting infringement of the newly-asserted claims.  Id. at *34.

A consideration for future litigants to keep in mind is that “(1) if the PTAB issues a final judgment invalidating a patent claim; and (2) if another claim in that same patent is at issue in a district court litigation; and (3) if any differences between the two claims do not materially alter the question of invalidity regarding the district court claim; then (4) the patentee will be collaterally estopped from litigating the district court claim (assuming the other requirements of the collateral estoppel doctrine are met).”  Id. at *9.

Tags

estoppel, infringement

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Consumer Goods and Services

Related Offices

Atlanta, GA

London

Washington, DC

Contacts

Milan Feliciello
Associate
Washington, DC
+1 202 408 4317
Email
Shannon M. Patrick
Associate
Atlanta, GA
+1 404 653 6558
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email


Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 



DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Seminar

IP Strategy at the Crossroads: Technology, Enforcement, and Contracts

May 15, 2026

Taipei

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP